Indoleamine 2,3-Dioxygenase (IDO) Activity: A Perspective Biomarker for Laboratory Determination in Tumor Immunotherapy
Metabolism of tryptophan and the action of IDO (indoleamine 2,3-dioxygenase) inhibitors in the tryptophan metabolic pathway. In vivo, ~95% of L-tryptophan is catabolized via IDO in the form of kynurenine degradation products. Additional enzymatic metabolites in the pathway promote immune suppression. IDO inhibitors primarily compete with tryptophan by binding to the catalytic domain of IDO or non-competitive mechanisms to affect tryptophan metabolism, thereby exerting an inhibitory effect on IDO. IDO1, indoleamine 2,3-dioxygenase 1; IDO2, indoleamine 2,3-dioxygenase 2; TDO, tryptophan dioxygenase; FAMID, formamidase; KATs, kynurenine aminotransferases; KMO, kynurenine 3-monooxygenase; KYNU, kynureninase; 3HAAO, 3-hydroxyanthranilic acid dioxygenase; QPRT, quinolinic-acid phosphoribosyl transferase; NAD+, nicotinamide adenine dinucleotide; GCN2, general control nondepressible-2; mTORC1, mammalian target of rapamycin complex 1; AhR, aryl hydrocarbon receptor; Treg cells, regulatory T cells.
Publication
Indoleamine 2,3-Dioxygenase (IDO) Activity: A Perspective Biomarker for Laboratory Determination in Tumor Immunotherapy. (2023) Pengbo Yang, et al. Biomedicines. 2023 Jul;11(7):1988. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | TDO | TDO | ncbigene_synonym | DLX3 | 1747 |
| Homo sapiens | Primates | TDO | TDO | ncbigene_synonym | TDO2 | 6999 |
| Homo sapiens | Primates | HIDO1,IDO2,TDO-95% | IDO2 | ncbigene_symbol | IDO2 | 169355 |
| Homo sapiens | Primates | KMO | KMO | ncbigene_symbol | KMO | 8564 |
| Homo sapiens | Primates | KYNU | KYNU | ncbigene_symbol | KYNU | 8942 |
| Homo sapiens | Primates | GCN2 | GCN2 | ncbigene_synonym | EIF2AK4 | 440275 |
| Homo sapiens | Primates | mTORC1 | MTORC1 | famplex_relations | MTOR | 2475 |
| Homo sapiens | Primates | mTORC1 | MTORC1 | famplex_relations | RPTOR | 57521 |
| Homo sapiens | Primates | AhR | AHR | ncbigene_symbol | AHR | 196 |
| Homo sapiens | Primates | QPRT | QPRT | ncbigene_symbol | QPRT | 23475 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| BMS-986205 | NA | mesh:C095300 | ||
| PF-06840003 | NA | mesh:D010977 | ||
| L-tryptophan | NA | |||
| Trp | NA | mesh:C509690 | ||
| N-formyl kynurenine | NA | mesh:C029366 | ||
| Kynurenine | NA | mesh:C029366 | ||
| 3-hydroxykynurenine | NA | mesh:C402223 | ||
| KYNU | NA | |||
| 3-hydroxyanthranilic acid | NA | mesh:D015095 | ||
| Kynurenic acid | NA | mesh:D007736 | ||
| Aminocarboxymuconic semialdehyde | NA | mesh:C009338 | ||
| Xanthurenic acid | xanthurenic acid | mesh:C028330 | xanthurenic acid | chebi:10072 |
| Quinolinic acid | NA | mesh:D017378 | ||
| NAD | NAD | mesh:D009243 | NAD(+) | chebi:15846 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| semialdehyde | NA | mesh:C566402 |